Home | Clinical Care | Research | Training | Division Activities

Education and Training:

B.S., Chemistry, University of Michigan, Ann Arbor, Michigan (1962)

M.D., The Johns Hopkins University, Baltimore, MD (1966)

Intern and Assistant Resident, Barnes Hospital, St. Louis, MO (1966-68)

Postdoctoral Fellow, Laboratory of Biochemistry, National Heart and Lung Institute, National Institutes of Health, Bethesda, MD (1968-70)

Internist, Flight Surgeon, U.S. Air Force School of Aerospace Medicine, Brooks AFB, TX (1970-72)

Senior Fellow in Hematology, University of Washington, Department of Medicine, Seattle, WA (1972-75)

Thomas H. Price, M.D.
Professor of Medicine, Division of Hematology
University of Washington School of Medicine

Medical Director and Executive Vice President, Medical Division,
Puget Sound Blood Center

Office Address:
Puget Sound Blood Center
Box 359190
921 Terry Avenue,
Seattle, WA 98104-1256

Phone:   (206) 292-6571
Fax:       (206) 292-8030
E-mail:    thprice@psbc.org


CURRENT CLINICAL INTERESTS

Hematopoietic stem cell donation by unrelated donors


CURRENT RESEARCH INTERESTS
Research on neutrophil preservation and function, apheresis, hematopoietic growth factors in transfusion medicine


RESEARCH DESCRIPTION

The laboratory is involved in a multicenter Phase I/II study on the use of granulocytes obtained from normal donors stimulated with G-CSF and dexamethasone to treat patients with neutropenia and documented bacterial or fungal infection. Goals are to determine the feasibility of using community donors for stimulated granulocyte collections, the yields obtainable using this strategy, the hematological response in recipients, adverse effects in both donors and recipients, and whether or not the infused cells are able to function in the recipients. Controlled randomized trials will follow these studies if warranted by the data.

Studies in progress to determine the viability and storage characteristics of neutrophils collected from normal subjects stimulated with G-CSF.

We have also been active in the evaluation of new apheresis equipment and the optimization of platelet and neutrophil yields using these machines.

Evaluation of adverse effects experienced by hematopoietic stem cell donors under the National Marrow Donor Program.


SELECTED PUBLICATIONS

Price TH, Ochs HD, Gershoni-Baruch R, Harlan JM, Etzioni A: In vivo neutrophil and lymphocyte function studies in a patient with leukocyte adhesion deficiency type II. Blood 84:1666-72, 1994.

Price TH, Goodnough LT, Vogler WR, Sacher RA, Hellman RM, Johnston MFM, Bolgiano DC, Abels RI: The effect of human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter randomized double-blind controlled trial. Transfusion 36:29-36, 1996.

Price TH, Chatta GS, Dale DC: The effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans.  Blood 88:335-340, 1996.

Price TH: The current prospects for neutrophil transfusions for the treatment of granulocytopenic infected patients. Trans. Med. Rev. 14(1):2-11, 2000.

Price TH, Bowden RA, Boechkh M, Bux J, Nelson K, Liles WC, and Dale DC: Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation. Blood 95:3302-3309, 2000.